Hemo Organic

Hemo Organic Equity

The The Equity of Hemo Organic (524590.BO) as of Oct 21, 2026 is -1.52 M INR. In the previous year, The Equity was -3.15 M INR — a change of -51.97% (higher).

Equity

-1.52 MINR

YoY

-51.97%

Last updated:

In 2025, Hemo Organic's equity was -1.52 M INR, a -51.97% increase from the -3.15 M INR equity in the previous year.

The Hemo Organic Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2014
14.79 M INR
Jan 1, 2015
12.40 M INR
Jan 1, 2016
4.17 M INR
Jan 1, 2017
4.03 M INR
Jan 1, 2023
-512,500.00 INR
Jan 1, 2024
-3.15 M INR
Jan 1, 2025
-1.52 M INR
The Hemo Organic Equity history
YEAREquityYoY
-1.52 MINR-51.97%
-3.15 MINR+515.41%
-512,500.00INR-112.70%
4.03 MINR-3.23%
4.17 MINR-66.37%
12.40 MINR-16.19%
14.79 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Hemo Organic Stock analysis

What does Hemo Organic do? Hemo Organic Ltd develops chloro chemicals for pharmaceuticals and leather industry applications. The company manufactures ayurvedic and unani pharmaceutical preparations. It produces chemical products, pharmaceuticals, and medical chemicals. The firm's primary customers include pharmaceutical manufacturers and leather industry producers who purchase its chloro chemicals. The company's manufacturing focus on ayurvedic and unani pharmaceuticals targets traditional medicine segments. Hemo Organic Ltd serves the pharmaceutical and leather sectors with its chemical solutions. Hemo Organic Ltd specializes in chloro chemical development for pharmaceutical and leather industry use. The firm's ayurvedic and unani pharmaceutical manufacturing caters to traditional medicine markets. Chemical and medical chemical production supports both pharmaceutical and leather industry needs. The company's products are sold to manufacturers in the pharmaceutical sector and leather processing industry. Its business model centers on supplying chemical solutions to these two industrial segments. Hemo Organic is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Hemo Organic's Equity

Hemo Organic's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Hemo Organic's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Hemo Organic's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Hemo Organic's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Hemo Organic’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Hemo Organic stock

The Equity of Hemo Organic is -1.52 M INR in 2025.

The Equity of Hemo Organic changed from -3.15 M INR to -1.52 M INR, representing a -51.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Hemo Organic since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Hemo Organic historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Hemo Organic

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Hemo Organic